Myoma Clinical Trial
Official title:
Enclosed Electromechanical Morcellation and Vaginal Removal During Laparoscopic Myomectomy
Laparoscopic tissue removal is one of the most challenging parts for the laparoscopic surgery. For this reason, electromechanical morcellation has long been used to facilitate the tissue removal in gynecology. However, electromechanical morcellation has long been performed inside the abdomen without any containment. Therefore, this practice has recently undergone increased scrutiny because of important concerns related to tissue dissemination during intracorporeal power morcellation. Thus, the US Food and Drug Administration released a safety communication discouraging power morcellation in laparoscopic hysterectomy and myomectomy procedures in April 2014. As a result of this serious concern, the enclosed laparoscopic power morcellation has been come into prominence in gynecological surgery. Besides the removal of the tissues through vagina with posterior colpotomy is considered an another solution for this critical problem. In the literature the comparison for the two techniques for tissue removal is considerably scarce. Therefore researchers are aiming to prepare a trial to compare the laparoscopic enclosed electromechanical morcellation and tissue removal thorough vagina with posterior colpotomy according to surgical time, postoperative pain and postoperative sexual function.
In this study researchers aiming to compare the compare the laparoscopic enclosed electromechanical morcellation and tissue removal thorough vagina with posterior colpotomy according to surgical time, postoperative pain and postoperative sexual function. Patients with an indication of myomectomy, between 18 to 40 years old, without prior abdominal surgery and without suspicious of malignancy will include into the study. Anticipated number of the patients will be 60. Participants will be randomized into two groups; group 1 enclosed electromechanical morcellation will be performed to remove the myoma out of the abdominal cavity; group 2 myoma will be removed through vagina with posterior colpotomy. In group 1, after extirpation of the myoma from the uterus and repair of the uterine defect, the myoma will be removed from the abdomen with an enclosed laparoscopic electromechanical morcellation with using surgical glove. In group 2, after extirpation of myoma from uterus and repair of the uterine defect, myoma will be removed through the vagina with posterior colpotomy. In this group myoma will also be removed in a enclosed fashion with using endo bag. Tissue removal time (for group 1 removal time is decided time between the insertion and removal of the morcellation, for group two removal time is decided time between start of the posterior colpotomy and end of the closure of the posterior colpotomy), postoperative time and sexual function of the patient and any of the complications will be compared. Visual pain score and female sexual function index questionnaire will be used to assess the postoperative pain and sexual function, respectively. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00528177 -
Morphine vs. Oxycodone for Postoperative Pain Management
|
Phase 4 | |
Completed |
NCT05925153 -
Vision Screening Study for College Students at Nankai University
|
||
Completed |
NCT00891657 -
Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy
|
N/A | |
Completed |
NCT03972917 -
Observation of Long-term Effects on Endometrium and Uterine Fibroids in Women With Ulipristal Acetate Therapy
|
||
Completed |
NCT02747550 -
Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy
|
N/A | |
Completed |
NCT00898170 -
Effect of Myoma Removal on Blood Pressure and Erythropoetin Level
|
N/A | |
Withdrawn |
NCT02377492 -
Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy
|
N/A | |
Recruiting |
NCT05806307 -
Methods Decreasing Bleeding in Open Myomectomy
|
Phase 4 | |
Recruiting |
NCT00351494 -
Myoma Microvascularization Analysis Using Sonovue Before and After Uterine Artery Embolization
|
N/A | |
Completed |
NCT00562471 -
Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation
|
Phase 1/Phase 2 | |
Recruiting |
NCT01564602 -
To Compare to 2-channel and Multiple-channel Single Port Laparoscopic-assisted Vaginal Hysterectomy
|
N/A | |
Completed |
NCT01032213 -
Effect of Magnesium Sulphate on Coagulation
|
N/A | |
Completed |
NCT03427671 -
OCL 500 Treatment of Women With Symptomatic Uterine Fibroids
|
N/A | |
Not yet recruiting |
NCT04694677 -
Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.
|
N/A | |
Completed |
NCT04983719 -
Transcervical Myoma Biopsy Video
|
||
Recruiting |
NCT05170230 -
The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
|
N/A | |
Recruiting |
NCT05683041 -
Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy
|
N/A | |
Recruiting |
NCT05242783 -
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Using Haemostatic Tourniquets:
|
N/A | |
Recruiting |
NCT05266534 -
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
|
N/A | |
Completed |
NCT02853695 -
Implementation of Hysteroscopy in Flanders and the Netherlands
|